Key terms
About NVCT
Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NVCT news
No recent news articles are available for NVCT
No recent press releases are available for NVCT
NVCT Financials
Key terms
Ad Feedback
NVCT Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NVCT Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range